The system can lock its payload in place and control how it is released
A new injectable material designed to deliver drug therapies and sensor technology to targeted areas within the human body is being developed by a Texas A&M University biomedical engineer who says the system can lock its payload in place and control how it is released.
The research, led by Michael McShane, professor in the Department of Biomedical Engineering who specializes in biomaterials, and graduate student Jason Roberts, appears in “Journal of Materials Chemistry B.” It details the development of a carrier system embedded with microscopic capsules that act as tiny reservoirs for medicines or even sensors that would alert a person in critical instances, such as when blood-sugar levels change.
The technology, McShane notes, affords researchers a high degree of control over what is delivered to the body, where and when it is delivered and how much of it is delivered. That degree of flexibility, he says, could make the system an extremely useful tool when it comes to targeted drug delivery.
As opposed to having patients simply swallow a pill, health care professionals have long envisioned delivering specific quantities of medicines to targeted areas of the body, thereby increasing the treatment’s effectiveness while reducing side effects. In order to achieve this, a “vehicle” of sorts is needed to safely and accurately deliver the medicine to the desired location within the body.
McShane’s team, which also includes graduate student Dustin Ritter, is building that vehicle using a modified Jell-O-like substance known as a hydrogel. A hydrogel is a polymer mesh material that is typically biocompatible, meaning it allows cells within the body to conduct normal physiological processes without triggering an immune response from the host. Because of this, hydrogels are widely used in tissue engineering research, and they can be found in a number of other applications, most commonly as the material from which contact lenses are made.
Although hydrogels aren’t new, the ones employed in McShane’s carrier system aren’t typical; they’ve been enhanced. Specifically, they are embedded with tiny capsules that are significantly smaller than the width of a human hair. Each of these microcapsules serves as a reservoir or depot for the material doctors and researchers want to deliver, such as a drug.
Measuring a few microns in diameter, these porous microparticles are made from clusters of calcium carbonate nanoparticles that have been deliberately formed around a specific material to trap it inside, McShane notes. Once the desired material is trapped within the microsphere, multiple layers of polymers are wrapped around the particles, he explains. This allows for a precise and customizable control over how the microcapsule will release its contents when it interacts with its surrounding environment, McShane explains.
The system, McShane says, is not limited to drug delivery. In fact, it has shown promising results with biosensors. In these types of applications, he explains, the microcapsules carry a payload, such as a protein, that is responsive to something in the body that doctors want to measure. This measurable material is allowed to pass into the hydrogel and into the capsules where it triggers some type of optical change, he says. For example, McShane has been able to trigger a color change in the material (observable with a reader device) when pH and oxygen levels change or when blood-sugar levels fluctuate. It’s work that could translate into safer and more effective ways for people, such as those suffering from diabetes, to monitor their conditions.
The Latest on: Targeted drug delivery
via Google News
The Latest on: Targeted drug delivery
- Vascular Therapies Completes Upsized $17.3 Million Private Financingon January 28, 2020 at 10:00 am
and was increased from an originally-targeted $15 million up to $17.3 million, based upon interest from new investors, including a strategic foreign healthcare company. Vascular Therapies plans to use ...
- Ophthalmic Drug Delivery Devices Market Is Booming Worldwide Scrutinized in New Researchon January 28, 2020 at 9:57 am
The global ophthalmic drug delivery devices market is driven by rise in prevalence of glaucoma & macular degeneration, low bioavailability of drugs in conventional ophthalmic therapies, and rise in ...
- Using Protein Interaction Networks to Optimize Drug Deliveryon January 27, 2020 at 12:27 am
The benefit of this technique is that the user can quantify in real-time how much of the drug gets to the tumor and the time it remains there ... expert scientific support, and fast international ...
- Medtronic introduces Efficio software to help clinicians efficiently manage targeted drug delivery therapy with SynchroMed IIon January 26, 2020 at 10:30 pm
Medtronic plc, one of world’s largest medical technology, services and solutions companies, announced the launch of Efficio, a cloud-based data management software for use with the SynchroMed II ...
- Medtronic Launches Efficio™ Software to Help Clinicians Efficiently Manage Targeted Drug Delivery Therapy with SynchroMed™ IIon January 23, 2020 at 4:12 pm
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT) today announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal drug delivery ...
- Medtronic Launches Efficio Software to Help Clinicians Efficiently Manage Targeted Drug Delivery Therapy with SynchroMed IIon January 23, 2020 at 4:30 am
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of Efficio, a cloud-based data management software for use with the SynchroMed II intrathecal drug ...
- Medtronic Launches Efficio(TM) Software to Help Clinicians Efficiently Manage Targeted Drug Delivery Therapy with SynchroMed(TM) IIon January 23, 2020 at 4:30 am
Efficio Software Provides Enhanced, Secure Access to Patient Data and Delivers Actionable Insights in a Secure Cloud Environment DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc MDT, +0.64% ...
- Red blood cells recruited for targeted drug deliveryon January 22, 2020 at 7:35 am
An effective approach for targeted drug delivery is being pioneered by researchers from McMaster University, Red blood cells are modified to function as drug carriers. Source: McMaster ...
- Advanced and Targeted Drug Delivery Market Trends, Analysis, Statistics and Forecast 2019 to 2026on January 15, 2020 at 6:29 am
Jan 15, 2020 (Market Prediction via COMTEX) -- Ameco Research and new research report to its vast database titled "Global Advanced and Targeted Drug Delivery Market 2019" which provides extensive and ...
- Medtronic plc: New Study Finds Targeted Drug Delivery (TDD) is Associated with a Reduction in Health Care Utilization and Coston January 14, 2020 at 6:06 am
Before it's here, it's on the Bloomberg Terminal.
via Bing News